Status
Conditions
About
This longitudinal study aims to identify 1) a composite blood-based biomarker, 2) a composite electronic Smartphone-based biomarker and 3) a neurocognitive signature for bipolar disorder
Full description
The study will include 300 patients with newly diagnosed/first episode bipolar disorder, 200 healthy siblings or child family members and 100 healthy individuals without a family history of affective disorder. All individuals will be investigated with repeated blood tests, Smartphone recordings, neuropsychological tests and brain imaging during a five to ten year study period.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
700 participants in 3 patient groups
Loading...
Central trial contact
Marianne Meinertz; Lars V Kessing, Professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal